Get all your news in one place.
100's of premium titles.
One app.
Start reading
GOBankingRates
GOBankingRates
Travis Woods

Trump Tariffs on Pharmaceuticals Could Spike Costs 100% for Common Meds, Including Entresto to Keytruda

Aaron Schwartz / Pool via CNP / SplashNews.com

Despite President Donald Trump’s controversial tariff-launching “Liberation Day” being just over a year old — and with the legality of most of those tariffs stricken down by the Supreme Court — the Trump administration surprised the nation on Liberation Day’s first anniversary by announcing new tariffs on many brand-name drugs manufactured outside of the United States. This is a move that could, in the short term, radically increase the prices of your medication.

Trump’s plan? To levy a 100% tariff on pharmaceutical companies that manufacture drugs in foreign countries, rather than in America. It’s a policy designed to reshape the pharmaceutical industry in the long-term by incentivizing American manufacturing and price concessions, with large drug companies being given 120 days (and smaller companies 180 days) to negotiate the construction of American-based pharmaceutical plants to avoid the tariffs, per CNBC. The companies would then have until January 2029 to complete the actual plants.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.